Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Molecular Profile||Indication/Tumor Type||Response Type||Relevant Treatment Approaches||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|KIT T670I KIT D816V||Advanced Solid Tumor||decreased response||Midostaurin||Preclinical - Cell culture||Actionable||In a preclinical study, transformed cells co-expressing KIT D816V and KIT T670I demonstrated a decreased response compared to cells expressing KIT D816V alone when treated with Rydapt (midostaurin) in culture (PMID: 31270078).||31270078|
|KIT T670I KIT D816V||Advanced Solid Tumor||resistant||Avapritinib||Preclinical - Cell culture||Actionable||In a preclinical study, transformed cells co-expressing KIT D816V and KIT T670I demonstrated resistance to treatment with Ayvakit (avapritinib) in culture (PMID: 31270078).||31270078|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|